NovoCure Ltd (NVCR)
22.01
-0.16
(-0.72%)
USD |
NASDAQ |
May 17, 16:00
22.29
+0.28
(+1.27%)
After-Hours: 20:00
NovoCure Shareholders Equity (Quarterly): 359.36M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 359.36M |
| December 31, 2023 | 362.50M |
| September 30, 2023 | 393.70M |
| June 30, 2023 | 415.68M |
| March 31, 2023 | 432.15M |
| December 31, 2022 | 441.17M |
| September 30, 2022 | 445.40M |
| June 30, 2022 | 441.67M |
| March 31, 2022 | 435.88M |
| December 31, 2021 | 410.49M |
| September 30, 2021 | 413.16M |
| June 30, 2021 | 397.27M |
| March 31, 2021 | 372.13M |
| December 31, 2020 | 476.53M |
| September 30, 2020 | 307.04M |
| June 30, 2020 | 267.82M |
| March 31, 2020 | 241.95M |
| December 31, 2019 | 217.79M |
| September 30, 2019 | 190.36M |
| Date | Value |
|---|---|
| June 30, 2019 | 158.91M |
| March 31, 2019 | 126.39M |
| December 31, 2018 | 112.26M |
| September 30, 2018 | 114.94M |
| June 30, 2018 | 112.08M |
| March 31, 2018 | 106.12M |
| December 31, 2017 | 113.56M |
| September 30, 2017 | 116.68M |
| June 30, 2017 | 117.54M |
| March 31, 2017 | 128.90M |
| December 31, 2016 | 142.34M |
| September 30, 2016 | 158.24M |
| June 30, 2016 | 186.65M |
| March 31, 2016 | 220.43M |
| December 31, 2015 | 250.82M |
| September 30, 2015 | 121.22M |
| June 30, 2015 | 144.31M |
| December 31, 2014 | 97.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
158.91M
Minimum
Jun 2019
476.53M
Maximum
Dec 2020
359.05M
Average
395.49M
Median
Shareholders Equity (Quarterly) Benchmarks
| AtriCure Inc | 456.31M |
| NeuroMetrix Inc | 20.09M |
| Repligen Corp | 1.971B |
| Teleflex Inc | 4.503B |
| Perspective Therapeutics Inc | 229.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.121B |
| Total Liabilities (Quarterly) | 762.07M |
| Debt to Equity Ratio | 1.585 |
| Current Ratio | 6.258 |
| Net Debt Paydown Yield | -0.05% |